2018 West/Central CME

March 15-17, 2018 in Banff, Alberta

Scientific Program

The scientific program is subject to changes.

Sessions

President’s lecture: Perinatal death and hypoxic injury in Canada - Can we reduce the incidence?

8:00 AM to 8:30 AM
Room Name: Wildrose BC

Details:

At the end of this session, participants will be able to:

  • Understand the position of Canada and other high-income countries (HICs) with respect to perinatal loss;
  • Consider important causative factors that lead to preventable perinatal loss and injury;
  • Reflect on personal and institutional practices that may reduce perinatal loss and injury.
Speaker(s):

TVM complications

8:45 AM to 9:15 AM
Room Name: Wildrose BC

Details:

At the end of this session, participants will be able to:

  • Classify the presenting symptoms;
  • Identify the importance of dealing with early complications prior to tissue ingrowth;
  • Create an approach to delayed complications such as erosion or pain.
Speaker(s):

Compassion fatigue

10:30 AM to 11:00 AM
Room Name: Wildrose BC

Details:

At the end of this session, participants will be able to:

  • Demonstrate the interplay of compassion satisfaction and compassion fatigue in shaping professional quality of life (CanMEDS: Professional);
  • Assess the impact of burnout and secondary trauma on the development of compassion fatigue (CanMEDS: Collaborator);
  • Manage organizational factors to modify the risk of compassion fatigue (CanMEDS: Leader).
Speaker(s):

Little BIG Talk: Non-hormonal alternatives to menopausal hormone therapy

11:30 AM to 11:45 AM
Room Name: Wildrose BC

Details:

After this session, participants will be able to:

  • Discuss the validated symptoms of menopause;
  • Identify women who are not candidates for menopausal HRT;
  • Consider non-hormonal alternatives for menopausal symptoms;
  • Contemplate coming to the "Non-hormonal options for menopause symptoms" workshop to learn more!!!
Speaker(s):

HRT and menopause

11:45 AM to 12:20 PM
Room Name: Wildrose BC

Details:

At the end of this session, the participant will be able to:

  • Summarize recent and important menopausal publications, including the NAMS 2017 Position Statement with regards to menopausal hormone therapy;
  • Assist their patients to make informed choices about treatment;
  • Provide individualized care.

Click here for a video on Menopause and Hormone Therapy.

Speaker(s):

Workshops (1)

1:20 PM to 2:15 PM

Workshop 1A) The role of sexual assault on women's health

Room Name: Hawthorn A

Details:

At the end of this session, participants will be able to:

  • Describe the scope of the problem of sexual assault in Canada and its relevance to women’s health and safety;
  • Identify the negative effects of sexual assault myths and the benefits of a positive response to disclosures on women’s help-seeking;
  • Describe the clinical interventions of a sexual assault victim upon arrival to the Emergency Room;
  • Summarize the support services relative to police, forensic evidence collection, and follow-up for the victim;
  • Identify key issues sexual assault victims face as described through anecdotal case investigations.
Speaker(s):

Workshop 1B) Maintaining well-being for health care providers

Room Name: Hawthorn B

Details:

At the end of this session, participants will be able to:

  • Evaluate their own protective factors and risk factors for compassion fatigue using a professional quality of life measure (CanMEDS Professional and Collaborator);
  • Devise strategies to enhance their own resilience in the workplace (CanMEDS Professional and Collaborator);
  • Demonstrate how a quality of life measure can be useful for setting and measuring goals for personal well-being (CanMEDS Professional and Collaborator).
Speaker(s):

Workshop 1C) Non-hormonal alternatives to menopausal hormone therapy

Room Name: Hawthorn C

Details:

After this session, participants will be able to:

  • Discuss the validated symptoms of menopause, specifically, vasomotor concerns;
  • Identify women who are not candidates for menopausal HRT;
  • Consider non-hormonal alternatives for menopausal symptoms;
  • Work within a case-based structure to develop skills in treating menopausal symptoms.
Speaker(s):

Workshop 1D) Medico-legal: Issues in obstetrics

Room Name: Bluebell

Details:

At the end of this session, participants will be able to:

  • Describe the CMPA experience with obstetrical cases;
  • Identify medical legal hazards in obstetrics and;
  • Develop mitigation strategies for risks in obstetrics.
Speaker(s):

Little BIG Talk: Bacterial vaginosis

2:20 PM to 2:30 PM
Room Name: Wildrose BC

Details:

At the end of this session, participants will be able to:

  • Define Bacterial Vaginosis (BV);

  • Identify BV’s health implications;

  • Summarize current diagnostic tests and treatments available;

  • Describe the vaginal microbiome and how we define ‘dysbiosis’.

Speaker(s):

Little BIG Talk: HPV vaccination for prevention of recurring disease

2:35 PM to 2:45 PM
Room Name: Wildrose BC

Details:

At the end of this session, participants will be able to:

  • Review the risks and benefits regarding the HPV vaccine for women already attending colposcopy.

Click here for a video on The 6 things you need to know about HPV

Speaker(s):

Little BIG Talk: A new approach to the management of severe obstetrical hemorrhage

2:50 PM to 3:00 PM
Room Name: Wildrose BC

Details:

At the end of this session, participants will be able to:

  • Compare the different stages of obstetrical hemorrhage with a view to prevention of severe maternal morbidity and mortality;
  • Promote the use of objective quantification of blood loss in obstetrical hemorrhage;
  • Illustrate the value of standardized protocols and safety checklists in the management of postpartum hemorrhage;
  • Highlight team based interdisciplinary simulation as a safety initiative in the management obstetrical hemorrhage.
Speaker(s):

Workshops (2)

3:30 PM to 4:25 PM

Workshop 2A) Bacterial vaginosis

Room Name: Hawthorn A

Details:

At the end of this session, participants will be able to:

  • Define bacterial vaginosis and describe its health implications (Medical Expert);
  • Summarize current diagnostic tests and treatments available (Medical Expert);
  • Describe the vaginal microbiome and how we define dysbiosis.
Speaker(s):

Workshop 2B) HPV vaccination

Room Name: Hawthorn B

Details:

At the end of this session, participants will be able to:

  • Review the risks and benefits regarding the HPV vaccine for women already attending colposcopy;
  • Evaluate existing recommendations regarding the HPV vaccine for women attending colposcopy;
  • Reflect on the marketing for HPV vaccination;
  • Summarize the available evidence for HPV vaccinations for women attending colposcopy and incorporate it in individual patient counseling.

Click here for a video on The 6 things you need to know about HPV

Speaker(s):

Workshop 2C) A case-based approach to the management of severe obstetrical hemorrhage

Room Name: Hawthorn C

Details:

At the end of this session, participants will be able to:

  • Use case-based and interactive learning to develop an approach to the management of uterine atony;
  • Explain the role of tranexamic acid in the management of postpartum hemorrhage;
  • Recognize the presentation  and develop a management approach for hemorrhagic shock and disseminated intravascular coagulopathy;
  • Highlight team based interdisciplinary simulation as a safety initiative to prevent morbidity and mortality from obstetrical hemorrhage.
Speaker(s):

Workshop 2D) Medico-legal: Issues in gynaecology

Room Name: Bluebell

Details:

At the end of this session, participants will be able to:

  • Describe the CMPA experience with gynaecological cases;
  • Identify medical legal hazards in gynaecology and;
  • Develop mitigation strategies for risks in gynaecology.
Speaker(s):

An update on management of the second stage of labour

4:30 PM to 5:00 PM
Room Name: Wildrose BC

Details:

At the end of this session, participants will be able to:

  • Describe trends in route of delivery for 2nd stage arrest/fetal distress in Alberta and the impact on the Cesarean section rate, and explain why this has occurred;
  • Describe maternal outcomes with operative vaginal delivery;
  • Describe neonatal intercranial trauma by mode of delivery;
  • Explain if the mode of delivery in the 2nd stage affect subsequent pregnancy outcomes.
Speaker(s):

Advanced reproductive age

8:00 AM to 8:30 AM
Room Name: Wildrose BC

Details:

At the end of this session, participants will be able to:

  • Refer to the SOGC Clinical Practice Guideline on ‘Advanced Reproductive Age and Fertility’ for guidance in counseling patients;
  • Describe appropriate investigations and their timing in the context of advanced reproductive age (ARA);
  • Explain the available treatment options to patients with ARA;
  • Explain the technique of oocyte cryopreservation, its potential benefits and its limitations.
Speaker(s):

Concurrent gynaecology sessions (CS1)

8:35 AM to 11:35 AM

08:35 AM --- Concurrent 1A) Risks of LEEP – The colposcopists’ perspective

Room Name: Wildrose A

Details:

At the end of this session, participants will be able:

  • Review the literature dealing with the association of a prior cervical excisional procedure and the risk of preterm birth;
  • Review strategies to prevent overtreatment of young women with a diagnosis of cervical dysplasia;
  • Provide a framework for counseling women requiring treatment for cervical dysplasia.
Speaker(s):

09:05 AM --- Concurrent 1B) The risks of LEEP with respect to future pregnancies

Room Name: Wildrose A

Details:

At the end of this session, participants will be able to:

  • Identify the risks of adverse obstetrical outcomes following LEEP;
  • Define the efficacy of cervical length measurements in pregnant women with a previous LEEP;
  • Implement appropriate antenatal management strategies in women with a short cervix following LEEP;
  • Define the impact of possible “modifiable” factors such as LEEP-to-pregnancy interval, depth and number of LEEPs.
Speaker(s):

09:35 AM --- Concurrent 1C) Case presentations in colposcopy

Room Name: Wildrose A

Details:

At the end of this session, participants will be able to:

  • Review of management topics in colposcopy by case-based discussions.
Speaker(s):

10:05 AM --- Networking break and exhibits

Room Name: Wildrose Prefunction

10:35 AM --- Concurrent 1D) Hormonal contraception and the risk of breast cancer

Room Name: Wildrose A

Details:

At the end of this session, participants will be able to:

  • Summarize a current understanding of overall cancer risks and benefits of hormonal contraception (CanMEDS: Scholar, Medical Expert)
  • Appraise the findings of a recent landmark trial on hormonal contraception and risk of breast cancer in the context of previous observational data (CanMEDS: Scholar, Medical Expert)
  • Present absolute risks of hormonal contraception to patients with appropriate context and key counselling points (CanMEDS: Communicator, Health Advocate)
Speaker(s):

11:05 AM --- Concurrent 1E) Enhancing HPV vaccination in First Nations populations in Alberta (EHVINA Study)

Room Name: Wildrose A

Details:

At the end of this session, participants will be able to:

  • Describe social and system factors shaping First Nations patients and community experiences of HPV-related cancers (Communicator);
  • Examine the historical, social, and political contexts in which HPV prevention and treatment occur for First Nations people (Collaborator);
  • Re-examine physicians’ capacity to address system drivers of inequities in gynaecologic cancers in First Nations (Advocate).
Speaker(s):

Concurrent obstetrics and Early Risk Assessment (ERA) Program sessions (CS2)

8:35 AM to 11:35 AM

08:35 AM --- Concurrent 2A) ASA for the prevention of preeclampsia

Room Name: Wildrose BC

Details:

At the end of this session, participants will be able to:

  • Interpret the evidence for the recommended dose of ASA to prevent preeclampsia in pregnancy (medical expert/scholar);
  • Identify the evidence behind when to initiate ASA in pregnancy in order to prevent preeclampsia (medical expert/scholar);
  • Judge how to balance the benefits versus the risks in using ASA for the prevention of preeclamsia in pregnancy (scholar).
Speaker(s):

09:05 AM --- Concurrent 2B) Longterm cardiovascular risk for women with HTN/PET

Room Name: Wildrose BC

Details:

By the end of this session, the participant will
be able to:

  • Understand the impacts of hypertensive disorders of pregnancy on a woman’s future cardiovascular health:
    • Gestational Hypertension and Preeclampsia;
  • Describe postpartum clinical management strategies to reduce a woman’s future risk of cardiovascular disease:
    • Education, screening & treatment of CVD Risk Factors.
Speaker(s):

09:35 AM --- Concurrent 2C) Interpregnancy interval: Is there a Goldilocks Zone?

Room Name: Wildrose BC

Details:

At the end of this session, participants will be able to:

  • Define Interpregnancy Interval (IPI);
  • Describe the epidemiology of Short and Long IPIs;
  • Describe association of interpregnancy intervals.
Speaker(s):

10:05 AM --- Networking break and exhibits

Room Name: Wildrose Prefunction

10:35 AM --- Concurrent 2D) Before it is too late: Addressing maternal mortality and severe morbidity in our region

Room Name: Wildrose BC

Details:

At the end of this session, participants will be able to:

  • Illustrate the increasing concern of severe maternal morbidity (SMM) and mortality in our population;
  • Engage obstetrical care providers to develop a standardized approach of reporting and reviewing severe maternal morbidity;
  • Support ongoing strategies to address SMM and mortality by uses of check-sheets, protocols & inter-disciplinary simulation for maternal emergencies, including severe maternal hypertension, obstetrical hemorrhage, cardiac arrest and sepsis. 
Speaker(s):

11:05 AM --- Concurrent 2E) Indigenous health: Obstetrics

Room Name: Wildrose BC

Details:

At the end of this session, participants will be able to: 

  • Identify broader determinants of health relating to obstetrics in the Indigenous population;
  • Describe ways to genuinely collaborate with Indigenous communities using examples from a community-based research project targeting improved pregnancy-related health;
  • Identify and describe potential strategies for improving prenatal outcomes in Indigenous populations.
Speaker(s):

Harm reduction in pregnancy: More important than ever in light of the opioid crisis

11:40 AM to 12:10 PM
Room Name: Wildrose BC

Details:

At the end of this session, participants will be able to:

  • Identify the role of improving Social Determinants of Health as critical to improving outcomes
  • Explain “safe prescribing” to minimize the amount of drug that mom and baby are exposed to;
  • Explain “rooming in” as a “practice” to improve outcomes and minimize foster care placements;
  • Identify the role of trauma informed care in improving outcomes.

Of potential interest to participants:

Speaker(s):

9th Annual Alberta Colposcopy meeting

12:30 PM to 5:00 PM
Room Name: Wildrose A

Details:

The Alberta Cervical Cancer Screening Program is hosting the 9th Annual Meeting for Alberta Colposcopists  on Friday March 16, 2017 from 12:30 pm - 5:00 pm in the Wildrose A Ballroom.

 The focus of the day will be quality in colposcopy with didactic and interactive presentations. This year’s meeting will be focus on HPV testing and vaccination, patient   education, correlation between colposcopic impressions and biopsy results, and case presentations.This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the University of Calgary Office of Continuing Medical Education and Professional Development. You may claim a maximum of 3.5 hours (credits are automatically calculated).

This event is only open to Colposcopists and health professionals practicing in Alberta.

For more information and to register to attend, please contact Paul Wright at paul.wright2@albertahealthservices.ca.  

                

 

Application of ERAS to general gynaecology and minimally invasive surgery

8:00 AM to 8:40 AM
Room Name: Wildrose BC

Details:

After this session, participants will be able to:

  • Discuss your role within the multidisciplinary delivery of ERAS elements;
  • Apply the elements of ERAS currently used in oncology to benign gynecologic surgery;
  • Recognize how intraoperative interventions can influence both patient and societal outcomes;
  • Create strategies to overcome barriers to optimizing recovery.
Speaker(s):

Workshop (3)

8:45 AM to 9:40 AM

Workshop 3A) Transgender Health

Room Name: Hawthorn A

Details:

At the end of this session, participants will be able to:

  • Discuss the spectrum of gender identity;
  • Identify the potential for improvement in the experience of gender nonconforming individuals when accessing care;
  • Create a safe space for the gender non-conforming person seeking care;
  • Define ways in which this care may fall short for the gender diverse and remedy those.
Speaker(s):

Workshop 3B) Current management of assisted vaginal delivery

Room Name: Hawthorn B

Details:

At the end of this session, participants will be able to:

  • Recognize the changing trends in Operative Vaginal Delivery;
  • Appreciate the reasons for those trends;
  • Develop a management plan that you are comfortable with;
  • Realize the deficiencies in current consent process;
  • Understand Caesarian delivery is not the panacea.
Speaker(s):

Workshop 3C) Medical abortion

Room Name: Hawthorn C

Details:

At the end of this session, participants will be able to:

  • Provide evidence based best practices in 1st trimester medical abortion (MA) for undesired or failed pregnancies;
  • Recognize and manage complications;
  • Summarize the key resources on the Canadian Abortion Providers Support (CAPS) community of practice website;
  • Demonstrate how to use the CAPS clinical checklist for prescribers.
Speaker(s):

Workshop 3D) Member’s choice - Speaking up… and listening up: Part 1

Room Name: Bluebell
Speaker(s):

Workshop (4)

10:10 AM to 11:05 AM

Workshop 4A) Pain, pills, and pot: A review of chronic opioid therapy and medical cannabis in the treatment of chronic non-cancer pain

Room Name: Hawthorn A

Details:

At the end of this session, participants will be able to:

  • List the Canadian opioid guidelines for Chronic Non Cancer pain (Scholar);
  • Evaluate a patient's response to Opioid Tapering - Health Advocate (Communicator);
  • Quantify the risks and benefits of Medical Cannabis in Chronic Non Cancer Pain (Medical expert).
Speaker(s):

Workshop 4B) Fetal health surveillance workshop

Room Name: Hawthorn B

Details:

At the end of this session, participants will be able to:

  • Identify the physiology of FH rate changes (Scholar);
  • Identify the appropriate method of intrapartum surveillance (Medical Expert);
  • Provide effective IA (Medial Expert);
  • Practice systematic interpretation of EFM tracings (Medical Expert);
  • Manage atypical & abnormal fetal surveillance (Collaborator);
  • “Guess” several case outcomes (Medical Expert).
     
Speaker(s):

Workshop 4C) How social media affects patients' views of their healthcare

Room Name: Hawthorn C

Details:

At the end of this session, participants will be able to:

  • Identify the functional characteristics and corresponding issues related to different types of social media/social networking sites;
  • Review, interpret, and evaluate social media research projects in science and health related contexts;
  • Evaluate how social media might be influencing their particular field;
  • Develop strategies to tackle social media issues as they apply to their particular contexts. 
Speaker(s):

Workshop 4D) Member’s choice - Speaking up… and listening up: Part 2

Room Name: Bluebell
Speaker(s):

PCOS indications for reproductive health – Both obstetrical and gynaecological aspects

11:10 AM to 11:40 AM
Room Name: Wildrose BC

Details:

At the end of this session, participants will be able to:

  • Define and diagnose PCOS as a spectrum;
  • Discuss reproductive health issues and beyond in PCOS;
  • Identify known and putative risk factors for pregnancy complications;
  • Create an awareness not to “stereotype” women with PCOS.
Speaker(s):

Late use of antenatal corticosteroids

11:40 AM to 12:20 PM
Room Name: Wildrose BC

Details:

After this session, participants will be able to:

  • Understand the pros and cons of late gestational steroids;
  • Identify potential patients who might benefit from late gestational steroids;
  • Consider the risks of late preterm delivery;
  • Improve the accuracy of timing of steroids.
Speaker(s):